Safer Compounding in Hospitals Act of 2024
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Safer Compounding in Hospitals Act of 2024 is a legislative proposal introduced in the House during the 118th Congress aimed at improving safety standards for pharmaceutical compounding practices within hospital settings. The bill was referred to the Subcommittee on Health but did not advance further and is currently classified as failed or expired. Specific provisions, detailed policy measures, and regulatory changes intended by the bill are not available in the provided source data.
This bill sought to enhance safety in hospital drug compounding but did not progress beyond initial committee referral and is no longer active in the current Congress.
- The bill focuses on the health policy area, specifically targeting compounding practices in hospitals.
- It was introduced in the House of Representatives and referred to the Subcommittee on Health on December 17, 2024.
- No official summary or full text is available, limiting detailed analysis of its provisions.
['Hospital patients who receive compounded medications', 'Hospital pharmacy departments', 'Healthcare providers involved in medication preparation and administration']
['Lack of available full text and summary limits understanding of implementation requirements and costs.', 'Unclear authority and oversight mechanisms due to missing detailed provisions.', 'Potential tradeoffs between regulatory burden on hospitals and patient safety improvements cannot be assessed.']
The bill was introduced during the 118th Congress and referred to a relevant subcommittee but did not advance, indicating limited legislative momentum or prioritization within the current session. No further legislative actions or debates are recorded.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential improvements in hospital compounding safety could reduce medication errors and adverse patient outcomes if implemented.', 'Increased regulatory requirements might lead to higher operational costs for hospital pharmacies.', 'Enhanced oversight could influence hospital pharmacy staffing and training practices.']
The absence of both the full bill text and an official summary significantly limits transparency and public understanding of the bill's specific provisions and intended impacts. This lack of information poses challenges for oversight and informed legislative debate. Additionally, the bill's failure to progress beyond subcommittee referral suggests limited engagement or prioritization during the 118th Congress.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.